Sr. Territory Account Manager (Mountain West)
Illumina- Full Time
- Senior (5 to 8 years)
Employment Type: Full-time
Location Type: [Not Specified]
Salary: $95,000 - $150,000 (California range; may vary for other locations like Colorado, Illinois, New York. Actual salary may vary based on qualifications and experience.)
Passionate about precision medicine and advancing the healthcare industry? Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
The MRD Clinical Account Executive is responsible for promoting and selling Tempus's Minimal Residual Disease (MRD) testing services to clinicians and healthcare providers. This role involves strategic business development, collaboration with key stakeholders, and driving the adoption of MRD testing within academic medical centers, health systems, and community practices.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical, and other benefits depending on the position.
Note on Criminal History: For remote roles open to individuals in unincorporated Los Angeles, Tempus reasonably believes that criminal history may have a direct, adverse and negative relationship with the job duties of engaging positively with customers, potentially resulting in the withdrawal of a conditional offer of employment.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.